Ballentine Partners, LLC - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.

Quarter-by-quarter ownership
Ballentine Partners, LLC ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$304,241
-22.8%
1,403
-35.4%
0.01%
-30.0%
Q1 2023$394,340
+22.1%
2,171
+32.1%
0.01%0.0%
Q4 2022$322,850
+23.7%
1,643
+41.6%
0.01%
+11.1%
Q3 2022$261,0001,1600.01%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 1,952,441$150,963,00011.19%
Eventide Asset Management 901,077$69,671,0001.36%
First Light Asset Management, LLC 128,200$9,912,0001.02%
Prosight Management, LP 15,826$1,224,0000.58%
MOODY ALDRICH PARTNERS LLC 30,970$2,395,0000.50%
PFM Health Sciences, LP 137,960$10,667,0000.49%
Rock Springs Capital Management LP 244,106$18,874,0000.48%
Atika Capital Management LLC 73,500$5,683,0000.46%
Hood River Capital Management LLC 132,400$10,237,0000.44%
CATALYST PRIVATE WEALTH, LLC 5,006$387,0000.38%
View complete list of KARUNA THERAPEUTICS INC shareholders